0001493152-23-006675.txt : 20230303
0001493152-23-006675.hdr.sgml : 20230303
20230303161026
ACCESSION NUMBER: 0001493152-23-006675
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230303
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CASAMENTO CHARLES J
CENTRAL INDEX KEY: 0001117167
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38738
FILM NUMBER: 23704006
MAIL ADDRESS:
STREET 1: 99 BELBROOK WAY
CITY: ATHERTON
STATE: CA
ZIP: 94027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001710340
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371858472
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21925 W. FIELD PARKWAY
STREET 2: SUITE 235
CITY: DEER PARK
STATE: IL
ZIP: 60010-7278
BUSINESS PHONE: (847) 787-7361
MAIL ADDRESS:
STREET 1: 21925 W. FIELD PARKWAY
STREET 2: SUITE 235
CITY: DEER PARK
STATE: IL
ZIP: 60010-7278
4
1
ownership.xml
X0306
4
2023-03-03
0
0001710340
Eton Pharmaceuticals, Inc.
ETON
0001117167
CASAMENTO CHARLES J
21925 W FIELD PKWY,
SUITE 235
DEER PARK
IL
60010-7278
1
0
0
0
Stock Option (Right to buy)
3.47
2023-03-03
4
A
0
25000
0.00
A
2033-02-19
Common stock
25000
134555
D
Option was approved by the Compensation Committee of the Board of Directors as of February 20, 2023 and approved by the full Board of Directors on March 3, 2023.
The shares subject to the option shall vest on a quarterly basis over 12 months form the date of grant until fully vested and exercisable on February 20, 2024.
The reporting person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration.
/s/ James R Gruber
2023-03-03